Rising Medicare Part D premiums may push more beneficiaries toward Medicare Advantage plans.
The Trump administration ended a program early that had helped keep prescription drug plan costs lower.
That program had reduced premiums for standalone Medicare Part D plans in recent years.
Without it, Part D premiums are expected to increase significantly in 2026.
Medicare Advantage plans often include prescription drug coverage as part of their bundled benefits.
These plans could attract members seeking more predictable costs amid rising Part D premiums.
Industry analysts predict a shift in enrollment as seniors weigh their options.
The policy change alters the financial landscape for millions of Medicare beneficiaries.
Standalone drug plans may struggle to compete with the all-in-one appeal of Medicare Advantage.
